Includes Akkermansia muciniphila, Clostridium butyricum, and Bifidobacterium infantischosen to support healthy gutbrain signaling for craving regulation, plus metabolic support for an active lifestyle
GLP-1 therapy is a medical approach that helps support appetite control, portion awareness, and feelings of fullness
From 2008-2010, Sanofi-Aventis Acomplia (selective CB1 antagonist) and Abbott Laboratories Meridia (NE/5-HT reuptake inhibitor)--both also designed to suppress appetite--were pulled from the market over similar cardiac safety concerns
Endogenous GLP-1 is rapidly degraded primarily by dipeptidyl peptidase-4 (DPP-4), as well as neutral endopeptidase 24.11 (NEP 24.11) and renal clearance, resulting in a half-life of approximately 2 minutes
They reheat well, they freeze well, and they taste good cold if necessary
hs-CRP, high-sensitivity C-reactive protein